Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 5/20 | 0.59 |
| ▸ | HSD17B2 | P37059 | 5/20 | 0.59 |
| ▸ | APP | P05067 | 5/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | FLT3 | P36888 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.42 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.42 |
| ▸ | ESRRG | P62508 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PRF1 | P14222 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12562798 | 1.00 | HSD17B1 (0.59) | HSD17B1HSD17B2APPESR1ESR2 | |
| SCHEMBL12562788 | 1.00 | HSD17B1 (0.59) | HSD17B1HSD17B2APPESR1ESR2 | |
| SCHEMBL12562792 | 1.00 | HSD17B1 (0.59) | HSD17B1HSD17B2APPESR1ESR2 | |
| SCHEMBL12562796 | 0.97 | HSD17B1 (0.61) | HSD17B1HSD17B2APPESR1ESR2 | |
| SCHEMBL12562851 | 0.97 | HSD17B1 (0.61) | HSD17B1HSD17B2APPESR1ESR2 | |
| SCHEMBL12581415 | 0.95 | HSD17B1 (0.63) | HSD17B1HSD17B2APPESR1ESR2 | |
| SCHEMBL10471775 | 0.84 | HSD17B1 (0.50) | HSD17B1HSD17B2APPESR1ESR2 | |
| SCHEMBL13480627 | 0.84 | NFE2L2 (0.50) | HSD17B1HSD17B2APPESR1ESR2 | |
| SCHEMBL12562813 | 0.83 | HSD17B1 (0.58) | HSD17B1HSD17B2APPESR1ESR2 | |
| SCHEMBL12562815 | 0.83 | HSD17B1 (0.58) | HSD17B1HSD17B2APPESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8598151-B2 | Solid solution inducing layer for weak epitaxy growth of non-planar phthalocyanine | SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) | 2013-12-03 | — | — | US | disclosed |
| US-20120153265-A1 | SOLID SOLUTION INDUCING LAYER FOR WEAK EPITAXY GROWTH OF NON-PLANAR PHTHALOCYANINE | CHANGCHUN FLEXIBLE DISPLAY TECHNOLOGY CO., LTD. (CN) | 2012-06-21 | — | — | US | disclosed |
| US-20110152541-A1 | INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE | SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) | 2011-06-23 | — | — | US | disclosed |
| US-20110152541-A1 | INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE | SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120153265-A1 | SOLID SOLUTION INDUCING LAYER FOR WEAK EPITAXY GROWTH OF NON-PLANAR PHTHALOCYANINE | PAX3, TCF7L2, TCF7 | HSD17B1 1354/4885HSD17B2 1105/4885APP 1509/4885 |
| US-20110152541-A1 | INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE | CDYL, PAX3, PAXBP1 | HSD17B1 2793/4885HSD17B2 2870/4885APP 2590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.